http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2625044-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f73dac012733ce8c3dbda5177dc07f71 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-735 |
filingDate | 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdd798de6c2087465082e07ad142657 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c4adda74bd1525a3c6713e3a642f4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf853ec4266400281dddddd74c9b05d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c8fd5b47c53ac6c2e94c230dc373f6 |
publicationDate | 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2625044-T3 |
titleOfInvention | A pharmaceutical composition for use in the treatment or prevention of an inflammatory disease or an autoimmune disease, or both |
abstract | Pharmaceutical composition for use in the treatment or prevention of an inflammatory disease or an autoimmune disease, or both, in which the pharmaceutical composition comprises soluble Fcγ receptor (RFcγ) as an active ingredient and in which the pharmaceutical composition is designed to administer a first dose of a therapeutically effective amount of soluble RFcγ, followed by a safety period of several weeks, followed by a subsequent cycle of treatment of at least two more administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient. |
priorityDate | 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.